Advertisement

Topics

Mologen: Results Of The Extension Phase Of The Exploratory Phase Ib/Iia Study In HIV

20:00 EDT 8 Aug 2017 | BioSpace

BERLIN--(BUSINESS WIRE)--The biopharmaceutical company MOLOGEN AG (ISIN DE0006637200; Frankfurt Stock Exchange Prime Standard: MGN) announced the key results of the extension phase of the exploratory phase Ib/IIa TEACH trial to evaluate lefitolimod in HIV-positive (HIV: human immunodeficiency virus) ...

Original Article: Mologen: Results Of The Extension Phase Of The Exploratory Phase Ib/Iia Study In HIV

NEXT ARTICLE

More From BioPortfolio on "Mologen: Results Of The Extension Phase Of The Exploratory Phase Ib/Iia Study In HIV"

Quick Search
Advertisement
 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...